Əsas səhifə

Çap

Əks əlaqə

İnfo
Fish oils in the care of coronary heart disease (CHD) patients

Mündəricat

Fish oils in the care of coronary heart disease (CHD) patients

Sübutlu məlumatların xülasələri
08.11.2017 • Sonuncu dəyişiklik 08.11.2017
Editors

Omega-3 fatty acids appear to reduce total mortality and the risk of death due to myocardial infarction in CHD patients, but there is no evidence of the benefit in patients taking statins.

A systematic review including 10 studies with a total of 14727 subjects was abstracted in DARE. Daily intake of omega-3 fatty acids for a mean duration of 37 months decreased all cause mortality by 16% (RR 0.84, 95% CI 0.76 to 0.94, 6 studies) and the risk of death due to MI by 24% (RR 0.76, 95%CI 0.66 to 0.88, 4 studies). There were no statistically significant differences between the fish oil and placebo groups for any of the other outcomes: nonfatal MI (RR 1.03, 95% CI 0.87 to 1.19, 7 studies), nonfatal stroke (RR 1.36, 95% CI 0.87 to 2.29, 3 studies), and angina pectoris (RR 1.03, 95% CI 0.85 to 1.20, 7 studies). There is absence of data in patients receiving statins.

Comment: The quality of evidence downgraded by indirectness (absence of data in patients receiving statins).

Ədəbiyyat

  1. Yzebe D, Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004 Oct;18(5):581-92.